Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant PAPPA anticorps (AA 351-523)

L’anticorps anti-PAPPA Monoclonal Lapin est utilisé pour la détection de PAPPA dans des échantillons de Humain. Il a été validé pour IHC.
N° du produit ABIN7864293
639,45 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Recombinant PAPPA anticorps (AA 351-523) (ABIN7864293)

Antigène

Voir toutes PAPPA Anticorps
PAPPA (Pregnancy-Associated Plasma Protein A, Pappalysin 1 (PAPPA))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 122
  • 24
Humain

Hôte

  • 78
  • 51
  • 1
Lapin

Clonalité

  • 82
  • 48
Monoclonal

Conjugué

  • 62
  • 14
  • 11
  • 8
  • 6
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp PAPPA est non-conjugé

Application

  • 51
  • 50
  • 33
  • 31
  • 20
  • 13
  • 13
  • 10
  • 7
  • 6
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

PAPPA-8804R
  • Épitope

    • 31
    • 15
    • 5
    • 5
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 351-523

    Fonction

    Recombinant PAPP-A / Pappalysin-1 (Marker of Atherosclerosis and Aneuploid Fetus) Antibody

    Specificité

    Pregnancy Associated Plasma Protein (PAPP-A) is found in maternal blood that increases as pregnancy progresses, although it is not specific to pregnancy. It is principally expressed in the syncytiotrophoblast of the placenta, which forms the main source of circulating maternal PAPP-A. It cleaves insulin-like growth factor binding proteins (IGFBPs), IGFBP-4 and IGFBP-5. IGFBP-4 cleavage is enhanced significantly in the presence of bound IGF, whereas IGFBP-5 cleavage is inhibited slightly by IGF presence. It is thought to be involved in local proliferative processes such as wound healing and bone remodeling. Low plasma level of this protein has been suggested as a biochemical marker for pregnancies with aneuploid fetuses. PAPPA has also been suggested as a potential biomarker of acute myocardial infarction and Coronary Artery Disease (CAD).

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant fragment (within aa 351-523) of human PAPP-A protein (exact sequence is proprietary)

    Isotype

    IgG, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Antigène

    PAPPA (Pregnancy-Associated Plasma Protein A, Pappalysin 1 (PAPPA))

    Autre désignation

    PAPP-A

    Sujet

    ASBABP2, Aspecific BCL2 ARE binding protein 2, Differentially placenta 1 expressed protein, DIPLA1, IGF-dependent, IGFBP4ase, Insulin-like growth factor-dependent IGF-binding protein 4 protease (IGFBP-4 protease), PAPA, PAPP A, PAPPA1, Pappalysin-1, Pregnancy Associated Plasma Protein A (PAPP-A)

    Human placenta tissue.

    Poids moléculaire

    181kDa

    ID gène

    5069, 643599

    UniProt

    Q13219
Vous êtes ici:
Chat with us!